[Polaris Pharmaceuticals-KY] Announcement of Board Resolution on Pricing Matters for Cash Increase Private Placement of Common Stock
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Polaris Pharmaceuticals-KY announced its board of directors has resolved to conduct a private placement of common stock. The reference price is NT$18.44 per share, with the actual placement price set at NT$18.00. The company plans to issue up to 150,000,000 shares, and the funds raised will be used for working capital and loan repayment.